U.S. Department of Defense Invests In Prostrate Cancer Treatment
Filed under: Business Line, Companies, Congress, Contract Awards, Department of Defense, Events, Federal Budget Process, S&T, SRI International, Services, development program
The U.S. Department of Defense/Prostrate Cancer Research Program (DoD/PCRP) gave a grant of just over $1.5 million dollars to SRI International to support pre-clinical studies of the non-profit organization’s agents that might be able to develop into drugs to treat prostate cancer. This grant follows an earlier one that had led to some positive results utilizing plant products.
The U.S. defense budget contains a great deal of novel R&D efforts and a lot of funding. Congress has used it to fund breast and other cancer and disease prevention and treatment research. Obviously the military has a great deal invested in their human capital and medical treatment and this funding helps in those areas. SRI International is a spin-off of Stanford University specializing in sponsored research for government, businesses and foundations.
-
Search This Site
Custom Search -
Recent Posts
- Oshkosh Defense Receives $84 Million Award for M-ATV Armor Kits — Press Release
- EchoStorm Releases Next Generation Software for Intelligence, Surveillance, and Reconnaissance — Press Release
- ATK and NASA to Perform Final Ground Test for the Space Shuttle Program — Press Release
- Japan To Add To Fighter Contests
- Taiwan Continues Buying Foreign Weapon Systems
-
-
-
-
-
FREE Business Downloads
-
Latest Defense News
More Defense News -->
-
Content from our trusted partner BNETGet your own CBS Interactive Widget.>GET IT NOW
get your job site
at simplyhired.com
[...] This post was mentioned on Twitter by Dagpotter, DefProcureNews. DefProcureNews said: U.S. Department of Defense Invests In Prostrate Cancer Treatment: The U.S. Department of Defense/Prostrate Canc.. http://bit.ly/w9kGs [...]